Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
30/07/202422:50PR Newswire (US)Healthcare IT Market size is set to grow by USD 199.8 billion from 2024-2028, Increasing focus on improving quality of services and efficiency to boost the market growth, Technavio
30/07/202422:50PR Newswire (US)Synthetic Biology Market size is set to grow by USD 55.60 BILLIOn from 2024-2028, growing applications leading to growing adoption of synthetic biology boost the market, Technavio
30/07/202422:45PR Newswire (US)NASA Sets Coverage for Northrop Grumman's 21st Station Resupply Launch
30/07/202422:45PR Newswire (US)SNDL Announces 2024 Annual General Meeting ResultsNASDAQ:SNDLSundial Growers Inc
30/07/202422:41UK Regulatorytrivago Deepens Partnership With Ai-Driven Tech Platform HolistoTG:TVAGTrivago ADS
30/07/202422:38UK RegulatoryAduro Clean Technologies tritt in neue Phase der Zusammenarbeit mit TotalEnergies einTG:9D50Aduro Clean Technologies Inc
30/07/202422:38UK RegulatoryAduro Clean Technologies entame une nouvelle phase de collaboration avec TotalEnergiesTG:9D50Aduro Clean Technologies Inc
30/07/202422:35PR Newswire (US)T. ROWE PRICE GROUP DECLARES QUARTERLY DIVIDENDNASDAQ:TROWT Rowe Price Group Inc
30/07/202422:30UK RegulatoryDBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the ReportEU:DBVDBV Technologies
30/07/202422:30UK RegulatoryDBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the ReportTG:DBVDBV Technologies
30/07/202422:30UK RegulatoryDBV Technologies publie son Rapport Financier Semestriel 2024 ― Modalités de mise à disposition ou de consultationEU:DBVDBV Technologies
30/07/202422:30UK RegulatoryDBV Technologies publie son Rapport Financier Semestriel 2024 ― Modalités de mise à disposition ou de consultationTG:DBVDBV Technologies
30/07/202422:30UK RegulatoryRemuneration of Directors by distribution of Millicom (Tigo) shares
30/07/202422:30PR Newswire (US)Telehealth Market size is set to grow by USD 368.7 billion from 2024-2028, Increasing cases of chronic diseases boost the market, Technavio
30/07/202422:30PR Newswire (US)Lundin Mining Second Quarter 2024 ResultsTSX:LUNLundin Mining Corporation
30/07/202422:28PR Newswire (US)Ecopetrol announces the dates for the publication of its second quarter 2024 report and conference callNYSE:ECEcopetrol SA
30/07/202422:26PR Newswire (US)TEAMSTERS AT RICHMOND PUBLIC SCHOOLS SECURE HISTORIC FIRST CONTRACT
30/07/202422:26PR Newswire (US)ICONIX ANNOUNCES THE EXPIRATION AND RESULTS OF ITS CASH TENDER OFFER FOR CLASS A-2 NOTES
30/07/202422:25PR Newswire (US)Lundin Mining Announces Declaration of Regular DividendTSX:LUNLundin Mining Corporation
30/07/202422:25PR Newswire (US)Energy-based Non-invasive Medical Aesthetic Treatment System Market size is set to grow by USD 1.84 billion from 2023-2027, Growing awareness about the availability of energy-based non-invasive medical aesthetic treatment systems to boost the market growth
30/07/202422:20PR Newswire (US)Atomic Spectroscopy Market size is set to grow by USD 2.46 billion from 2024-2028, Increased funding by government organizations for environmental testing and product safety to boost the market growth, Technavio
30/07/202422:20PR Newswire (US)Drug Discovery Informatics Market size is set to grow by USD 7.28 billion from 2024-2028, Increasing R and D investments by pharmaceutical and biopharmaceutical companies boost the market, Technavio
30/07/202422:19PR Newswire (US)Ryerson Reports Second Quarter 2024 ResultsNYSE:RYIRyerson Holding Corporation
30/07/202422:17UK RegulatoryPoste Italiane net profit exceeds €1 bln in first half of 2024; CEO: successful business model
30/07/202422:17PR Newswire (US)Gel Documentation Systems Market size is set to grow by USD 52.21 million from 2023-2027, Increase in use of molecular biology techniques in clinical practice boost the market, Technavio
30/07/202422:15UK RegulatoryNew Clinical Data Demonstrates Three Years of Continuous Treatment with Dual-Acting LEQEMBI® (lecanemab-irmb) Continues to Significantly Benefit Early Alzheimer’s Disease Patients Presented at The Alzheimer’s Association International Conference (AAICTG:IDPBiogen Inc
30/07/202422:15UK RegulatoryNew Clinical Data Demonstrates Three Years of Continuous Treatment with Dual-Acting LEQEMBI® (lecanemab-irmb) Continues to Significantly Benefit Early Alzheimer’s Disease Patients Presented at The Alzheimer’s Association International Conference (AAICXE:IDPBiogen Inc
30/07/202422:15UK RegulatoryNew Clinical Data Demonstrates Three Years of Continuous Treatment with Dual-Acting LEQEMBI® (lecanemab-irmb) Continues to Significantly Benefit Early Alzheimer’s Disease Patients Presented at The Alzheimer’s Association International Conference (AAICBIT:1BIIBBiogen Inc
30/07/202422:15UK RegulatoryNew Clinical Data Demonstrates Three Years of Continuous Treatment with Dual-Acting LEQEMBI® (lecanemab-irmb) Continues to Significantly Benefit Early Alzheimer’s Disease Patients Presented at The Alzheimer’s Association International Conference (AAICLSE:0R1BBiogen Inc
30/07/202422:15PR Newswire (US)NEW GOLD REPORTS SECOND QUARTER 2024 RESULTSAMEX:NGDNew Gold Inc

Your Recent History

Delayed Upgrade Clock